Ifosfamide and gemcitabine: A phase II trial in advanced inoperable non- small cell lung cancer

Seminars in Oncology

Volumn 25, Issue 1 SUPPL. 2, 1998, Pages 15-18

  Gatzemeier, U ^a   Manegold, C ^a   Eberhard, W ^a   Wilke, H J ^a   Chomy, F ^a   Chomy, P ^a   Khayat, D ^a   Blatter, J ^a   Seeber, S ^a   Drings, P ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE;

ADULT; ADVANCED CANCER; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INFECTION; INOPERABLE CANCER; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TOXICITY; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 18744434029     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)